The assay also could be complementary to FISH and IHC, which might further improve the accuracy and convenience of diagnosis and treatment of ALK rearrangement-positive lymphomas, or even other lymphomas of unknown origin with rare ALK-positive condition. This evidence concerns the gene ALK and lymphoma.